Combination therapy with a dipeptidyl peptidase-4 inhibitor and a proton pump inhibitor restores normoglycaemia in non-obese diabetic mice

被引：64

作者：

Suarez-Pinzon, W. L. ^{[1
]}

Cembrowski, G. S. ^{[2
]}

Rabinovitch, A. ^{[1
]}

机构：

[1] Univ Alberta, Dept Med, Edmonton, AB T6G 2E1, Canada

[2] Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB T6G 2E1, Canada

来源：

DIABETOLOGIA | 2009年 / 52卷 / 08期

关键词：

Dipeptidyl peptidase-4; Gastrin Glucagon-like peptide-1; NOD mice Proton pump inhibitor; Type; 1; diabetes; GLUCAGON-LIKE PEPTIDE-1; BETA-CELL SURVIVAL; NOD MICE; IV; HYPERGASTRINEMIA;

D O I：

10.1007/s00125-009-1390-z

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

引用

页码：1680 / 1682

页数：3

共 11 条

[1]

The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes [J].

Drucker, Daniel J. ;

Nauck, Michael A. .

LANCET, 2006, 368 (9548) :1696-1705

[2]

Double incretin receptor knockout (DIRKO) mice reveal an essential role for the enteroinsular axis in transducing the glucoregulatory actions of DPP-IV inhibitors [J].

Hansotia, T ;

Baggio, LL ;

Delmeire, D ;

Hinke, SA ;

Yamada, Y ;

Tsukiyama, K ;

Seino, Y ;

Holst, JJ ;

Schuit, F ;

Drucker, DJ .

DIABETES, 2004, 53 (05) :1326-1335

[3]

Randomized prospective trial of the effect of induced hypergastrinemia on the prevention of pancreatic atrophy after pancreatoduodenectomy in humans [J].

Jang, JY ;

Kim, SW ;

Han, JK ;

Park, SJ ;

Park, YC ;

Ahn, YJ ;

Park, YH .

ANNALS OF SURGERY, 2003, 237 (04) :522-529

[4]

DEGRADATION OF GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE AND TRUNCATED GLUCAGON-LIKE PEPTIDE-1 IN-VITRO AND IN-VIVO BY DIPEPTIDYL PEPTIDASE-IV [J].

KIEFFER, TJ ;

MCINTOSH, CHS ;

PEDERSON, RA .

ENDOCRINOLOGY, 1995, 136 (08) :3585-3596

[5]

Dipeptidyl Peptidase IV Inhibition With MK0431 Improves Islet Graft Survival in Diabetic NOD Mice Partially via T-Cell Modulation [J].

Kim, Su-Jin ;

Nian, Cuilan ;

Doudet, Doris J. ;

McIntosh, Christopher H. S. .

DIABETES, 2009, 58 (03) :641-651

[6]

Maida A, 2008, DIABETOLOGIA, V51, pS363

[7]

Chronic inhibition of dipeptidyl peptidase-4 with a sitagliptin analog preserves pancreatic β-cell mass and function in a rodent model of type 2 diabetes [J].

Mu, James ;

Woods, John ;

Zhou, Yun-Ping ;

Roy, Ranabir Sinha ;

Li, Zhihua ;

Zycband, Emanuel ;

Feng, Yue ;

Zhu, Lan ;

Li, Cai ;

Howard, Andrew D. ;

Moller, David. E. ;

Thornberry, Nancy A. ;

Zhang, Bei B. .

DIABETES, 2006, 55 (06) :1695-1704

[8]

Cure of overt diabetes in NOD mice by transient treatment with anti-lymphocyte serum and exendin-4 [J].

Ogawa, N ;

List, JF ;

Habener, JF ;

Maki, T .

DIABETES, 2004, 53 (07) :1700-1705

[9]

Dipeptidyl peptidase IV inhibitor treatment stimulates β-cell survival and islet neogenesis in streptozotocin-induced diabetic rats [J].

Pospisilik, JA ;

Martin, J ;

Doty, T ;

Ehses, JA ;

Pamir, N ;

Lynn, FC ;

Piteau, S ;

Demuth, HU ;

McIntosh, CHS ;

Pederson, RA .

DIABETES, 2003, 52 (03) :741-750

[10]

Combination Therapy With Glucagon-Like Peptide-1 and Gastrin Restores Normoglycemia in Diabetic NOD Mice [J].

Suarez-Pinzon, Wilma L. ;

Power, Robert F. ;

Yan, Yanhua ;

Wasserfall, Clive ;

Atkinson, Mark ;

Rabinovitch, Alex .

DIABETES, 2008, 57 (12) :3281-3288

← 1 2 →